Product Details: Thymalfasin

Thymalfasin is a synthetic peptide based on naturally occurring thymosin alpha-1, a research compound derived from preclinical studies of thymic peptides. In laboratory settings, it is investigated for its potential role in modulating immune pathways in preclinical models. Thymalfasin is supplied in a lyophilized powder form, which can be reconstituted according to experimental protocols.

In experimental studies, Thymalfasin is examined for its ability to interact with molecular pathways involved in immune signaling and cellular modulation in preclinical models. Early laboratory observations suggest it may influence the behavior of immune cells and related signaling processes.

Mechanism of Action

Upon administration to preclinical models, Thymalfasin is expected to bind to specific receptors on research cell populations. This interaction may activate intracellular signaling cascades, potentially influencing the production and regulation of signaling molecules in experimental models.

Additionally, Thymalfasin may modulate pathways associated with cellular communication, helping researchers explore its effects on experimental immune responses in controlled studies.

Properties of Thymalfasin: 

• Molecular Formula: C129H215N33O55

• Molecular Weight: 3108.3 g/mol

• CAS Number: 69521-94-4

• PubChem CID: 16130571

• Synonym: 62304-98-7, Thymosin alpha1, Thymosin alpha 1, Zadaxin

Research Applications/Benefits of Thymalfasin

Immune Support:

In laboratory studies, T-cells and Natural Killer (NK) cells are critical for exploring immune system dynamics. Researchers have determined that Thymalfasin may influence the activity and behavior of these cells in preclinical models. Based on these findings, Thymalfasin is used as a tool to study potential pathways and mechanisms associated with immune responses in controlled experiments.

Studying Chronic Viral Infection Parameters:

While Thymalfasin has not been directly investigated as a treatment for chronic viral infections in preclinical models, it has been observed to impact cellular parameters such as T-cell and NK cell activity. Researchers use these observations to explore how immune cells respond under experimental viral exposure conditions in laboratory settings.

Vaccine Response Investigations:

Preclinical studies indicate that Thymalfasin may modulate T-cell activity, which in turn can affect interleukin signaling in experimental models. These interleukins may then influence B-cell activity in preclinical systems, providing a model to study enhanced immune responses to vaccines in laboratory research.

Why Choose BehemothLabz to Buy Thymalfasin

At Behemoth Labz, we understand that reproducibility and precision are critical in laboratory research. Our Thymalfasin is manufactured to strict preclinical-grade standards, ensuring consistency and purity across every batch.

Each lot undergoes independent laboratory testing to verify composition, concentration, and absence of contaminants, giving researchers confidence in experimental results. By providing detailed product documentation, we enable accurate planning and reporting for your preclinical studies.

We also offer secure, reliable shipping worldwide, along with confidential and protected payment options, so researchers can focus entirely on their experiments without concern for logistics or data privacy.

Disclaimer: This information is for educational purposes. We do not allow the human consumption of our products. All our products are sold for laboratory and research experiments.

References:

1. Thymalfasin: an immune system enhancer for the treatment of liver disease. (2004, December 1). PubMed. https://pubmed.ncbi.nlm.nih.gov/15641207/
2. Dominari, A., Hathaway III, D., Pandav, K., Matos, W., Biswas, S., Reddy, G., Thevuthasan, S., Khan, M. A., Mathew, A., Makkar, S. S., Zaidi, M., Fahem, M. M. M., Beas, R., Castaneda, V., Paul, T., Halpern, J., & Baralt, D. (2020). Thymosin alpha 1: A comprehensive review of the literature. World Journal of Virology, 9(5), 67–78. https://doi.org/10.5501/wjv.v9.i5.67